Abstract
Acute kidney injury is still a worldwide clinic problem that affects kidney function and associated with high mortality risk. Unfortunately, approximately 1.7 million people are thought to die from acute kidney injury each year. Boron element is defined as an “essential trace element” for plants and thought to have a widespread role in living organisms. Boric acid, which is one of the important forms of boron, has been extensively discussed for both medicinal and nonmedicinal purposes. However, there is a lack of data in the literature to examine the relationship between boric acid and antidiuretic hormone (ADH) antagonism in kidney injury. Thus, we aimed to investigate the effects of conivaptan as an ADH antagonist and boric acid as an antioxidant agent on the post-ischemic renal injury process. In this study, the unilateral ischemia–reperfusion (I/R) injury rat model with contralateral nephrectomy was performed and blood/kidney tissue samples were taken at 6th hours of reperfusion. The effects of 10 mg/mL/kg conivaptan and 50 mg/kg boric acid were examined with the help of some biochemical and histological analyses. We observed that conivaptan generally alleviated the destructive effects of I/R and has therapeutic effects. Also of note is that conivaptan and boric acid combination tended to show negative effects on kidney function, considering the highest BUN (78.46 ± 3.88 mg/dL) and creatinine levels (1.561 ± 0.1018 mg/dL), suggesting possibly drug-drug interaction. Although it has reported that conivaptan can interact with other active substances, no experimental/clinical data on the possible interaction with boric acid have reported so far.
Similar content being viewed by others
Data Availability
The authors confirm that the data supporting the findings of this study are available within the article.
References
Khan KNM, Hard GC, Alden CL (2013) Chapter 47 - Kidney. In: Haschek WM, Rousseaux CG, Wallig MA (eds) Haschek and Rousseaux’s Handbook of Toxicologic Pathology, 3rd edn. Academic Press, Boston, pp 1667–1773
Jager KJ, Kovesdy C, Langham R, Rosenberg M, Jha V, Zoccali C (2019) A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Nephrol Dial Transplant 34:1803–1805. https://doi.org/10.1093/ndt/gfz174
Gueguen Y, Rouas C, Leblond FA (2012) Kidney injury biomarkers. Nephrologie & Therapeutique 8(3):146–155. https://doi.org/10.1016/j.nephro.2012.02.004
Luyckx VA, Tonelli M, Stanifer JW (2018) The global burden of kidney disease and the sustainable development goals. Bull World Health Organ 96(6):414-422D. https://doi.org/10.2471/BLT.17.206441
KDIGO clinical practice Guideline for acute kidney injury (2012). Chapter 21: definition and classification of AKI. Kidney Int 2(Suppl 1):19–22
Lewington AJP, Cerdá J, Mehta RL (2013) Raising awareness of acute kidney injury: a global perspective of a silent killer. Kidney Int 84(3):457–467. https://doi.org/10.1038/ki.2013.153
Murugan R, Kellum JA (2011) Acute kidney injury: what’s the prognosis? Nat Rev Nephrol 7(4):209–217. https://doi.org/10.1038/nrneph.2011.13
Fung A, Zhao H, Yang B, Lian Q, Ma D (2016) Ischaemic and inflammatory injury in renal graft from brain death donation: an update review. J Anesth 30(2):307–316. https://doi.org/10.1007/s00540-015-2120-y
Zuk A, Bonventre JV (2016) Acute Kidney Injury. Annu Rev Med 67(1):293–307. https://doi.org/10.1146/annurev-med-050214-013407
Myers BD (1990) Nature of postischaemic renal ınjury following aortic or cardiac surgery. In: Bihari D., Neild G. (eds) Acute Renal Failure in the Intensive Therapy Unit. Current Concepts in Critical Care. Springer, London. https://doi.org/10.1007/978-1-4471-1750-6_15
Mir MC, Pavan N, Parekh DJ (2016) Current paradigm for ıschemia in kidney surgery. J Urol 195(6):1655–1663. https://doi.org/10.1016/j.juro.2015.09.099
Chatterjee PK (2007) Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review. Naunyn-Schmied Arch Pharmacol 376:1–43. https://doi.org/10.1007/s00210-007-0183-5
Koshimizu TA, Nakamura K, Egashira N, Hiroyama M, Nonoguchi H, Tanoue A (2012) Vasopressin V1a and V1b receptors: from molecules to physiological systems. Physiol Rev 92(4):1813–1864. https://doi.org/10.1152/physrev.00035.2011
Can B, Alataş Ö (2018) Cerebral edema and antidiuretic hormone antagonism. In CURRENT ACADEMIC STUDIES IN HEALTH SCIENCES- Volume II (First Edition) (pp. 39–56). Ivpe: Cetinje, Montenegro. ISBN 978–9940–540–53–1
Meijer E, Boertien WE, Zietse R, Gansevoort RT (2011) Potential deleterious effects of vasopressin in chronic kidney disease and particularly autosomal dominant polycystic kidney disease. Kidney Blood Press Res 34(4):235–244. https://doi.org/10.1159/000326902
Amro OW, Paulus JK, Noubary F, Perrone RD (2016) Low-osmolar diet and adjusted water ıntake for vasopressin reduction in autosomal dominant polycystic kidney disease: a pilot randomized controlled trial. Am J Kidney Dis 68(6):882–891. https://doi.org/10.1053/j.ajkd.2016.07.023
Palmer BF (2015) Vasopressin receptor antagonists. Curr Hypertens Rep 17(1):510. https://doi.org/10.1007/s11906-014-0510-4
Tahara A, Tomura Y, Wada KI, Kusayama T, Tsukada J, Takanashi M, Yatsu T, Uchida W, Tanaka A (1997) Pharmacological profile of YM087, a novel potent nonpeptide vasopressin V1A and V2 receptor antagonist, in vitro and in vivo. J Pharmacol Exp Ther 282(1):301–308
Wada K, Tahara A, Arai Y, Aoki M, Tomura Y, Tsukada J, Yatsu T (2002) Effect of the vasopressin receptor antagonist conivaptan in rats with heart failure following myocardial infarction. Eur J Pharmacol 450(2):169–177. https://doi.org/10.1016/S0014-2999(02)02101-5
Uluisik I, Karakaya HC, Koc A (2018) The importance of boron in biological systems. J Trace Elem Med Biol 45:156–162. https://doi.org/10.1016/j.jtemb.2017.10.008
Kar F, Hacioglu C, Senturk H et al (2020) The role of oxidative stress, renal inflammation, and apoptosis in post ischemic reperfusion injury of kidney tissue: the protective effect of dose-dependent boric acid administration. Biol Trace Elem Res 195:150–158. https://doi.org/10.1007/s12011-019-01824-1
Naghii MR, Mofid M, Asgari AR, Hedayati M, Daneshpour MS (2011) Comparative effects of daily and weekly boron supplementation on plasma steroid hormones and proinflammatory cytokines. Journal of Trace Elements in Medicine and Biology: Organ of the Society for Minerals and Trace Elements (GMS) 25(1):54–58. https://doi.org/10.1016/j.jtemb.2010.10.001
Devirian TA, Volpe SL (2003) The physiological effects of dietary boron. Crit Rev Food Sci Nutr 43(2):219–231. https://doi.org/10.1080/10408690390826491
Dinh AQ, Naeem A, Sagervanshi A, Wimmer MA, Mühling KH (2021) Boron uptake and distribution by oilseed rape (Brassica napus L.) as affected by different nitrogen forms under low and high boron supply. Plant Physiol Biochem 161:156–165. https://doi.org/10.1016/j.plaphy.2021.02.009
Pizzorno L (2015) Nothing Boring About Boron. Integrative medicine 14(4):35–48
Rondanelli M, Faliva MA, Peroni G, Infantino V, Gasparri C, Iannello G et al (2020) Pivotal role of boron supplementation on bone health: a narrative review. J Trace Elem Med Biol 62:126577. https://doi.org/10.1016/j.jtemb.2020.126577
Lopalco A, Lopedota AA, Laquintana V, Denora N, Stella VJ (2020) Boric acid, a Lewis acid with unique and unusual properties: formulation ımplications. J Pharm Sci 109(8):2375–2386. https://doi.org/10.1016/j.xphs.2020.04.015
Can B, Oz S, Sahinturk V, Musmul A, Alatas İO (2019) Effects of conivaptan versus mannitol on post-ıschemic brain ınjury and edema. The Eurasian journal of medicine 51(1):42–48. https://doi.org/10.5152/eurasianjmed.2019.18368
Senturk H, Kabay S, Bayramoglu G et al (2008) Silymarin attenuates the renal ischemia/reperfusion injury-induced morphological changes in the rat kidney. World J Urol 26:401–407. https://doi.org/10.1007/s00345-008-0256-1
Waynforth HB, Flecknell PA (1994) Experimental and surgical technique in the rat, 2nd edn. Academic Press Limited, London
Morgenthaler NG, Struck J, Jochberger S, Dunser MW (2008) Copeptin: clinical use of a new biomarker. Trends Endocrinol Metab 19(2):43–49. https://doi.org/10.1016/j.tem.2007.11.001
Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95(2):351–358. https://doi.org/10.1016/0003-2697(79)90738-3
Beutler E, Duron O, Kelly BM (1963) Improved method for the determination of blood glutathione. J Lab Clin Med 61:882–888
Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121–126. https://doi.org/10.1016/s0076-6879(84)05016-3
Cohen G, Dembiec D, Marcus J (1970) Measurement of catalase activity in tissue extracts. Anal Biochem 34:30–38. https://doi.org/10.1016/0003-2697(70)90083-7
Suzuki K, Ota H, Sasagawa S, Sakatani T, Fujikura T (1983) Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem 132(2):345–352. https://doi.org/10.1016/0003-2697(83)90019-2
Gornall AG, Bardawill CJ, David MM (1949) Determination of serum proteins by means of the biuret reaction. J Biol Chem 177(2):751–766
Shiva N, Sharma N, Kulkarni YA, Mulay SR, Gaikwad AB (2020) Renal ischemia/reperfusion injury: an insight on in vitro and in vivo models. Life Sci 256:117860. https://doi.org/10.1016/j.lfs.2020.117860
Yang L, Besschetnova TY, Brooks CR, Shah JV, Bonventre JV (2010) Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 16(5):535–543. https://doi.org/10.1038/nm.2144
sFu Y, Tang C, Cai J, Chen G, Zhang D, Dong Z, (2018) Rodent models of AKI-CKD transition. Am J Physiol Renal Physiol 315(4):F1098–F1106. https://doi.org/10.1152/ajprenal.00199.2018
Finn WF, Fernandez-Repollet E, Goldfarb D, Iaina A, Eliahou HE (1984) Attenuation of injury due to unilateral renal ischemia: delayed effects of contralateral nephrectomy. J Lab Clin Med 103(2):193–203
Varga G, Ghanem S, Szabo B, Nagy K, Pal N, Tanczos B, Somogyi V, Barath B, Deak A, Peto K, Nemeth N (2019) Renal ischemia-reperfusion-induced metabolic and micro-rheological alterations and their modulation by remote organ ischemic preconditioning protocols in the rat. Clin Hemorheol Microcirc 71(2):225–236. https://doi.org/10.3233/CH-189414
Bonventre JV, Yang L (2011) Cellular pathophysiology of ischemic acute kidney injury. J Clin Investig 121(11):4210–4221. https://doi.org/10.1172/JCI45161
Meurer M, Höcherl K (2019) Renal ischemia-reperfusion injury impairs renal calcium, magnesium, and phosphate handling in mice. Pflugers Arch 471(6):901–914. https://doi.org/10.1007/s00424-019-02255-6
Vaprisol (conivaptan hydrochloride) package insert 2006 Deerfield, IL: Astellas Pharma US, Inc
Walter KA (2007) Conivaptan: New treatment for hyponatremia. Am J Health Syst Pharm 64(13):1385–1395. https://doi.org/10.2146/ajhp060383
Ock S, Jo S, Lee JB, Jin Y, Jeong T, Yoon J, Park B (2016) Comprehensive interpretation of hyperglycemia and hyperosmolality on the clinical outcomes among ischemic stroke patients. Am J Emerg Med 34(12):2343–2350. https://doi.org/10.1016/j.ajem.2016.08.046
Green DR, Llambi F. (2015). Cell Death Signaling. Cold Spring Harb Perspect Biol 1;7(12):a006080. https://doi.org/10.1101/cshperspect.a006080
Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35(4):495–516. https://doi.org/10.1080/01926230701320337
Hongmei Z (2012) Extrinsic and ıntrinsic apoptosis signal pathway review. Apoptosis and Medicine. IntechOpen
Riedl SJ, Shi Y (2004) Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 5(11):897–907. https://doi.org/10.1038/nrm1496
Porter AG, Jänicke RU (1999) Emerging roles of caspase-3 in apoptosis. Cell Death Differ 6(2):99–104. https://doi.org/10.1038/sj.cdd.4400476
Robertson JD, Orrenius S (2000) Molecular mechanisms of apoptosis induced by cytotoxic chemicals. Crit Rev Toxicol 30(5):609–627. https://doi.org/10.1080/10408440008951122
Ortiz A, Justo P, Catalán MP, Sanz AB, Lorz C, Egido J (2002) Apoptotic cell death in renal injury: the rationale for intervention. Curr Drug Targets Immune Endocr Metabol Disord 2(2):181–192
Acknowledgements
The authors are thankful to the Director and workers of the Medical and Surgical Experimental Research Center of the University for their kind cooperation during the animal care.
Funding
This research was financially supported by the Scientific Research Projects Commission of the Eskisehir Osmangazi University (Eskişehir, Turkey) (Project #202011011).
Author information
Authors and Affiliations
Contributions
B.C., F.K., and H.Ş. designed the study. H.Ş., B.C., F.K., E.K., and M.Ö. performed surgical operations. B.C., F.K., E.K., M.Ö., G.K., and İ.Ö.A. analyzed biochemical experiments. D.B.D. performed histological analyses. F.K. and M.Ö. helped interpret the statistical data. B.C. wrote the paper and interpreted the data. All the authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics Approval
All animal research protocols in this study were approved by the Institutional Ethics Committee (HADYEK, Protocol #772/2019).
Consent for Publication
All authors have given consent for the manuscript to be published by the corresponding author.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Can, B., Kar, F., Kar, E. et al. Conivaptan and Boric Acid Treatments in Acute Kidney Injury: Is This Combination Effective and Safe?. Biol Trace Elem Res 200, 3723–3737 (2022). https://doi.org/10.1007/s12011-021-02977-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-021-02977-8